Before joining Sound Bioventures, Linda was an investment manager at Karolinska Development, where she worked for 4 years managing deal flow, leading investments and serving as board director in Henlez ApS, deputy board director in PharmNovo AB and Chair of the nomination committee of Promimic AB (publ.).
Linda also has prior experience as the CEO of a Swedish start up in cancer diagnostics where she was responsible for leading activities in clinical studies, product development, IP, fundraising and more. Prior to that, she worked at Boston Consulting Group, a management consultancy firm, where she focused exclusively on MedTech and Life Science projects.
Linda holds a M.Sc. in Biotechnology from the Royal Institute of Technology and a Ph.D. in enzymology from Karolinska Institutet.
Based in Stockholm, SE.